Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus
Jaquellyne Gurgel Penaforte-Saboia,1,2 Carlos Eduardo Barra Couri,3 Natasha Vasconcelos Albuquerque,1,4 Vanessa Lauanna Lima Silva,5 Natália Bitar da Cunha Olegario,1,2 Virgínia Oliveira Fernandes,1,2,4 Renan Magalhães Montenegro Junior1,2,4 1Clinical Research Unit,...
Main Authors: | Gurgel Penaforte-Saboia J, Couri CEB, Vasconcelos Albuquerque N, Silva VLL, Bitar da Cunha Olegario N, Oliveira Fernandes V, Montenegro RM Junior |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-02-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/emerging-roles-of-dipeptidyl-peptidase-4-inhibitors-in-delaying-the-pr-peer-reviewed-article-DMSO |
Similar Items
-
Dipeptidyl peptidase IV (DDP IV) in NASH patients
by: Yasemin H. Balaban, et al.
Published: (2007-10-01) -
CD26/dipeptidyl peptidase IV contributes to tumor metastasis in human lung adenocarcinoma
by: Lei Liu, et al.
Published: (2013-05-01) -
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
by: Kaisa Tasanen, et al.
Published: (2019-06-01) -
Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas
by: Ivana Matrasova, et al.
Published: (2017-09-01) -
Regulation of chemokine activity – a focus on the role of dipeptidyl peptidase IV/CD26
by: Mieke Metzemaekers, et al.
Published: (2016-11-01)